# A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis

> **NCT00883337** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 324 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon β-1a
- **DRUG:** Teriflunomide

## Key facts

- **NCT ID:** NCT00883337
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-09
- **Final completion:** 2015-05
- **Target enrollment:** 324 (ACTUAL)
- **Last updated:** 2016-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883337, "A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00883337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*